2,442
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Survivorship

Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 414-421 | Received 28 Oct 2022, Accepted 04 Apr 2023, Published online: 19 Apr 2023

References

  • Drummond MF, Sculpher MJ, Claxton K, et al., editors. Methods for the economic evaluation of health care programmes. 4th ed. Oxford: Oxford University Press; 2015.
  • Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390.
  • Sweegers MG, Altenburg TM, Chinapaw MJ, et al. Which exercise prescriptions improve quality of life and physical function in patients with cancer during and following treatment? A systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2018;52(8):505–513.
  • Mishra SI, Scherer RW, Snyder C, et al. Are exercise programs effective for improving health-related quality of life among cancer survivors? A systematic review and meta-analysis. Oncol Nurs Forum. 2014;41(6):E326–E342.
  • Stout NL, Baima J, Swisher AK, et al. A systematic review of exercise systematic reviews in the cancer literature (2005-2017). PM&R. 2017;9(9s2):S347–S384.
  • Potiaumpai M, Doerksen SE, Chinchilli VM, et al. Cost evaluation of an exercise oncology intervention: the exercise in all chemotherapy trial. Cancer Rep. 2022;5(3):e1490.
  • Edmunds K, Scuffham P, Reeves P, et al. Demonstrating the value of early economic evaluation alongside clinical trials: exercise medicine for men with metastatic prostate cancer. Eur J Cancer Care. 2021;30(5):e13479.
  • Mijwel S, Jervaeus A, Bolam KA, et al. High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship. J Cancer Surviv. 2019;13(2):244–256.
  • McTiernan A, Friedenreich CM, Katzmarzyk PT, et al. Physical activity in cancer prevention and survival: a systematic review. Med Sci Sports Exerc. 2019;51(6):1252–1261.
  • Biddle SJH, Batterham AM. High-intensity interval exercise training for public health: a big HIT or shall we HIT it on the head? Int J Behav Nutr Phys Act. 2015;12(1):95.
  • Wong JN, McAuley E, Trinh L. Physical activity programming and counseling preferences among cancer survivors: a systematic review. Int J Behav Nutr Phys Act. 2018;15(1):48.
  • Gubler-Gut BE, Pöhlmann J, Flatz A, et al. Cost-effectiveness of physical activity interventions in cancer survivors of developed countries: a systematic review. J Cancer Surviv. 2021;15(6):961–975.
  • Khan KA, Mazuquin B, Canaway A, et al. Systematic review of economic evaluations of exercise and physiotherapy for patients treated for breast cancer. Breast Cancer Res Treat. 2019;176(1):37–52.
  • Mewes JC, Steuten LM, Ijzerman MJ, et al. Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review. Oncologist. 2012;17(12):1581–1593.
  • van Waart H, van Dongen JM, van Harten WH, et al. Cost-utility and cost-effectiveness of physical exercise during adjuvant chemotherapy. Eur J Health Econ. 2018;19(6):893–904.
  • Kampshoff CS, van Dongen JM, van Mechelen W, et al. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors. J Cancer Surviv. 2018;12(3):417–429.
  • Demmelmaier I, Brooke HL, Henriksson A, et al. Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomised clinical trial. Scand J Med Sci Sports. 2021;31(5):1144–1159.
  • Ax AK, Husberg M, Johansson B, et al. Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project. Acta Oncol. 2022;61(7):888–896.
  • Ax AK, Johansson B, Lyth J, et al. Short- and long-term effect of high versus low-to-moderate intensity exercise to optimise health-related quality of life after oncological treatment-results from the Phys-Can project. Support Care Cancer. 2022;30(7):5949–5963.
  • Berntsen S, Aaronson NK, Buffart L, et al. Design of a randomized controlled trial of physical training and cancer (Phys-Can) – the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. BMC Cancer. 2017;17(1):218.
  • Mazzoni AS, Brooke HL, Berntsen S, et al. Exercise adherence and effect of self-regulatory behavior change techniques in patients undergoing curative cancer treatment: secondary analysis from the Phys-Can randomized controlled trial. Integr Cancer Ther. 2020;19:1534735420946834.
  • Husereau D, Drummond M, Augustovski F, et al. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BJOG. 2022;129(3):336–344.
  • The Swedish Tax Agency. [cited 2021 Dec 7]. Available from: https://www.skatteverket.se/privat/skatter/beloppochprocent/2021.4.5b35a6251761e6914204479.html#h-Bilersattningmilersattning
  • The National Board of Health and Welfare. Registers [cited 2022 June 1]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/
  • The National Board of Health and Welfare. Viktlistor för NordDRG: the National board of Health and Welfare [cited 2021 Aug 20]. Available from: https://www.socialstyrelsen.se/utveckla-verksamhet/e-halsa/klassificering-och-koder/drg/viktlistor/
  • FASS. Farmacevtiska specialiteter i Sverige. 2020. [cited 2020 Oct 20]. Available from: https://www.fass.se
  • Swedish Social Insurance Agency. [cited 2022 June 1]. Available from: https://www.forsakringskassan.se/
  • SCB statistikdatabasen. 2020. Available from: http://www.statistikdatabasen.scb.se/
  • The Riksbank (Sweden’s Central Bank). [cited 2021 Oct 7]. Available from: www.riksbank.se
  • EuroQol Group. EuorQol [cited 2022 Sept 2]. Available from: https://euroqol.org/
  • van Hout B, Janssen MF, Feng YS, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15(5):708–715.
  • Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–1108.
  • Burström K, Sun S, Gerdtham UG, et al. Swedish experience-based value sets for EQ-5D health states. Qual Life Res. 2014;23(2):431–442.
  • Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27(1):7–22.
  • Kaur MN, Yan J, Klassen AF, et al. A systematic literature review of health utility values in breast cancer. Med Decis Making. 2022;42(5):704–719.
  • Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;2012(8):Cd008465.
  • Fairman CM, Focht BC, Lucas AR, et al. Effects of exercise interventions during different treatments in breast cancer. J Community Support Oncol. 2016;14(5):200–209.